ORKA Q2 2023 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ORKAOruka Therapeutics, Inc.

$1B

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$29,000

Operating Income

-$2M

Net Income

-$1M

EPS (Diluted)

$-1.23

QoQ Revenue Growth

NaN%

Balance Sheet

Total Assets

$41M

Total Liabilities

$2M

Stockholders' Equity

$39M

Cash & Equivalents

$40M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$29,000	-$29,000	+0.0%
Operating Income	-$2M	-$2M	+18.8%
Net Income	-$1M	-$3M	+53.0%